Jerusalem Says Never. Beijing Says Nothing. Brussels Decides in 10 Days.

The government-veto risk we’ve flagged since Issue #1 stopped being a probability and became a policy position. At Sunday’s cabinet meeting (July 5), PM Netanyahu said the sale of ZIM to Hapag-Lloyd is not on the agenda at all, after a deputy minister warned against handing Israel’s maritime gateway to a buyer with Qatari and Saudi sovereign stakes. Defense Minister Israel Katz went further — formally adopting his ministry’s conclusion that the deal doesn’t adequately safeguard Israel’s security interests, and explicitly stating the government will exercise its Golden Share authority if necessary. Defense joins Agriculture, Economy, Transportation and the Shipping Authority in formal opposition. ZIM fell 6.8% Monday and the spread blew out 9.1pp to 46.0% — the widest we’ve ever carried.

Our read: in its current format the deal is effectively dead — what a 46% “spread” is actually pricing is standalone ZIM plus a call option on Hapag-Lloyd/FIMI restructuring to satisfy the defense establishment, or an Israeli-acceptable bidder re-emerging. ZIM says it continues working per the merger agreement; new CEO Chen Lichtenstein (effective July 1) inherits the fight. This is deep-distress territory now, not merger arb — we’ve removed it from our Risk/Reward Top 6 accordingly.

Two weeks ago AAUC blew out 14pp on an FT report of NDRC hesitation. Last week it recovered 10.6pp on nothing. This week it widened 8.9pp — also on nothing. Neither Allied Gold nor Zijin has said a word since the June 10 reaffirmation, and the market has now traded this spread from 35% to 24.5% and back to 33.4% on literally zero disclosure. That round trip is the tell: nobody has an information edge on Beijing. This is pure NDRC handicapping with the July 29 outside date now 17 days away.

The setup itself hasn’t changed an inch: every Canadian and African condition is satisfied, the PRC is the sole gate, and any extension past July 29 requires both parties to agree. Clearance = ~33% in under three weeks. A miss = an extension negotiation with a buyer Beijing has reportedly pressured on price. The sharpest binary in the tracker, now measured in days.

Diana spent the week escalating: a July 8 release publicly counting the days since Genco’s board went silent on the $27.34 proposal (nearly three weeks), urging holders to tender by Friday’s deadline as a show of support, and — the structural move — stating it intends to file an amended Schedule TO and an F-4 registration formalizing the $24.80-cash-plus-one-Diana-share offer as a real exchange offer. That converts the sweetened proposal from a letter the board can ignore into paper shareholders can act on.

The tender expired Friday, July 10 at 5pm ET. The last public count was 10.6M shares — 28.4% of the non-Diana float — as of June 26. Monday’s post-expiration tally is the single most important data point in this saga: if participation climbed meaningfully toward a majority, board resistance becomes untenable. The spread narrowed 4.3pp to 5.5% into expiration as the market priced a negotiated endgame.

What was “reportedly” last week is committed paper this week: Paramount formally affirmed to the European Commission that it will exit the United International Pictures distribution JV with Universal — the EC confirmed the filing and set its decision for July 22. Reuters sources say the remedy is likely to win approval, and Paramount says it “directly and comprehensively” addresses the Commission’s concerns. That makes July 22 the nearest major binary on the entire calendar.

The UK is the sharper residual risk — and the mechanics matter. Culture Secretary Lisa Nandy is “minded to intervene” on media plurality under the Enterprise Act: if she issues an intervention notice, the CMA’s Phase 1 report (due August 7) goes to her, and a minister — not a regulator — decides between clearance and a 5+ month investigation that pushes close into 2027. She has framed the case as precedent-setting for the streaming era. With DOJ, SAMR, ACCC and three more jurisdictions cleared, the $7B regulatory termination fee and post-September ticking fee remain the cushion. After SSTK died at a single national regulator’s door two weeks ago, we treat August 7 with respect.

On July 7, UP and NS filed the first portion of their supplemental responses to the STB’s May 28 information request — addressing TRRA, KCT and TTX control, and explicitly preserving the independence of those gateway and car-supply entities (TRRA divestiture committed, 50% KCT ownership without control, TTX sold down to 49%). It’s a named item from the Board’s decision, answered proactively and ahead of the July 27 full-supplement deadline — the right kind of progress on a deal that spent the spring looking stalled.

The applicants guide to a mid-2027 close, with the STB holding a 12-month evidentiary clock once the record is accepted. ~15% over roughly 12 months, a $2.5B reverse termination fee, and a review that is now visibly moving: that combination puts NSC into our Risk/Reward Top 6 for the first time, at #3. Organized opposition (BNSF, CPKC, Teamsters, Farm Bureau) remains the real risk — but the clock finally started.

TruBridge closed July 9 — IKS Health completed the $26.25/share acquisition ($557M), ending a deal we’d tracked at a 0.04% spread all week. Blackline Safety (Francisco Partners) and Olaplex (Henkel) also completed, and Calavo Growers finished its stock merger into Mission Produce — CVGW is delisted. (A data note on that one: its final-week “spread widening” on our screens was an artifact of stale post-delisting prints against the still-moving Mission Produce stock leg — not a real move, and we’ve corrected the movers table accordingly.) Meanwhile $EEX (Apollo, $5.03 — Onex’s 93% written consent means no vote, and Questex’s Paul Miller is already named to run the combined events platform) and $TALK (UHS, $5.25 — approved May 29, state healthcare sign-offs pending) are both trading within pennies of their offers. Expect completion announcements imminently.